Chitosan and blueberry treatment induces arginase activity and inhibits nitric oxide production during acetaminophen-induced hepatotoxicity
| dc.contributor.author | Özçelik, Eda | |
| dc.contributor.author | Uslu, Sema | |
| dc.contributor.author | Burukoğlu, Dilek | |
| dc.contributor.author | Musmul, Ahmet | |
| dc.date.accessioned | 2020-11-13T05:32:01Z | |
| dc.date.available | 2020-11-13T05:32:01Z | |
| dc.date.issued | 2014 | |
| dc.department | AÇÜ, Sağlık Bilimleri Fakültesi | en_US |
| dc.description.abstract | Background: Liver diseases have become a major problem of the worldwide. More than 50% of all cases of liver failure can be attributed to drugs. Among these, acetaminophen is the most common cause. Objective: The aim of this study was to investigate the the hepatoprotective effects of blueberry and chitosan on tissue arginase activity, ornithine and nitric oxide levels during the acetaminophen-induced hepatotoxicity. Materials and Methods: Acetaminophen (250 mg/kg body weight per day), blueberry (60 mg/kg body weight per day) and, chitosan (200 mg/kg body weight per day) were administered to the rats by oral gavage during the experimental period. Results: Blueberry and chitosan significantly decreased liver arginase activity and ornithine levelsand and increased nitric oxide levels. Glutathione levels were remarkably increased by chitosan and blueberry treatments. Conclusion: The results of the present study indicate that blueberry and chitosan effectively protected against the acetaminophen-induced hepatotoxicity. The hepatoprotective effect afforded by blueberry and chitosan can be attributed to its antioxidant and anti-inflammatory activities. | |
| dc.identifier.citation | Özçelik, E., Uslu, S., Burukoğlu, D., & Musmul, A. (2014). Chitosan and blueberry treatment induces arginase activity and inhibits nitric oxide production during acetaminophen-induced hepatotoxicity. Pharmacognosy Magazine, 10(38), 217-234. | en_US |
| dc.identifier.doi | 10.4103/0973-1296.133234 | |
| dc.identifier.endpage | 234 | en_US |
| dc.identifier.issue | 38 | en_US |
| dc.identifier.startpage | 217 | en_US |
| dc.identifier.uri | https://hdl.handle.net/11494/2450 | |
| dc.identifier.volume | 10 | en_US |
| dc.identifier.wosquality | N/A | |
| dc.indekslendigikaynak | Web of Science | |
| dc.indekslendigikaynak | PubMed | |
| dc.institutionauthor | Özçelik, Eda | |
| dc.language.iso | en | en_US |
| dc.publisher | Wolters Kluwer Medknow Publications | en_US |
| dc.relation.ispartof | Pharmacognosy Magazine | |
| dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı | en_US |
| dc.rights | info:eu-repo/semantics/openAccess | en_US |
| dc.subject | Acetaminophen hepatotoxicity | en_US |
| dc.subject | Arginase | en_US |
| dc.subject | Blueberry | en_US |
| dc.subject | Chitosan | en_US |
| dc.subject | Ornithine | en_US |
| dc.title | Chitosan and blueberry treatment induces arginase activity and inhibits nitric oxide production during acetaminophen-induced hepatotoxicity | en_US |
| dc.type | Article |












